Interrelationships between exogenous porcine somatotropin (PST) administration and dietary protein and energy intake on protein deposition capacity and energy metabolism of pigs

Dietary betaine and ractopamine combine to increase lean tissue deposition in finisher pigs, particularly gilts

Dietary ractopamine increases lean tissue deposition, with the responses most evident at ad libitum feed intakes whereas dietary betaine can improve growth by reducing maintenance requirements, with the greatest responses occurring when energy is limiting. This study was conducted to investigate the interactions between dietary ractopamine and betaine on growth and carcass characteristics in restrictively fed [31.0 MJ digestible energy (DE)/day for 14 days followed by 36.8 MJ DE/day for 21 days] boars and gilts. Forty individually penned pigs (58.4 kg) were allocated to a 2 × 2 × 2 factorial arrangement of treatments, with the respective factors being sex (gilt or boar), dietary betaine (0 and 1.5 g/kg betaine) and dietary ractopamine (0 and 10 ppm ractopamine) for 35 days. Over the first 14 days of the study when the restriction was greatest, daily gain was greater in pigs fed betaine (+8%, P = 0.04) and in boars (+12%, P = 0.005) but was not affected by ractopamine (P = 0.18). Lean deposition was greater in pigs fed betaine (+5%, P = 0.08) and in boars (+6%, P = 0.006) but was not affected by ractopamine (P = 0.57). However, there was an interaction (P = 0.03) between ractopamine and sex such that ractopamine increased lean deposition in gilts but not boars. Thus, betaine and ractopamine had additive effects on lean mass in gilts (+5.1 kg) but not boars. Fat deposition was less in pigs fed ractopamine (–8%, P = 0.05) and in boars (–17%, P < 0.001) but was not affected by betaine (P = 0.81). However, there was an interaction (P = 0.04) between dietary ractopamine and sex such that ractopamine decreased fat deposition in gilts (–14%) but not boars. In conclusion, dietary betaine and ractopamine may have additive effects on lean deposition and improve body composition in gilts but responses in boars are more equivocal.

Growth rate and changes of the somatotropic axis in beef cattle administered exogenous bovine somatotropin beginning at two hundred, two hundred fifty, and three hundred days of age

To determine the effects of bovine somatotropin (bST) treatment beginning at 3 ages on the growth rate and components of the somatotropic axis, 40 beef cattle (200 +/- 21 d of age) were randomly assigned to 1 of 4 treatments (10 animals/treatment). Three of the treatment groups received bST (33 mug/kg of BW) daily beginning at 200, 250, or 300 d of age until all animals reached 400 d of age; the fourth group served as controls (0 bST). Animals were housed in pens (5 animals per pen; 2 pens per treatment) and fed a diet formulated for an ADG of 1.2 kg/d. Feed intake (per pen) was measured daily, and BW was determined weekly. Blood samples (10 mL) and ultrasound measurements were collected at 200, 250, 300, 350, and 400 d of age. Serum concentrations of ST and IGF-I were determined by RIA and IGFBP-2 and -3 by ligand blot procedures. Overall, cattle gained 284.0 +/- 14.7 kg of BW with a treatment x week interaction (P < 0.01), such that during the treatment period ADG was 11.6, 8.7, and 15.8% greater (P < 0.05) in cattle treated with bST beginning at 200, 250, and 300 d, respectively, relative to controls during the same time frame. Average DMI was 13.6% less (P < 0.05) in bST-treated cattle than in controls. Increases in ADG coupled with a reduction in DMI resulted in 11.7, 14.0, and 26.4% increases (P < 0.01) in the efficiency of gain (G:F) in bST-treated cattle beginning at 200, 250, and 300 d of age, respectively, compared with contemporary controls. Backfat thickness increased (P < 0.05) over time, but the magnitude of the increase was less in the bST-treated cattle (treatment x week interaction; P < 0.05). Area of the LM increased (P < 0.05) over time but was similar across treatment groups. Serum concentrations of ST, IGF-I, and IGFBP-3 increased (P < 0.05), whereas IGFBP-2 decreased (P < 0.05) over time. The changes in the components of somatotropic axis were more pronounced in bST-treated cattle compared with controls, with the greatest magnitude of response in animals that began bST treatment at 300 d of age. In conclusion, the exogenous bST-induced growth response was greater in animals that began to receive bST administration at 300 d of age and received it for a shorter period (100 d) compared with animals that received bST beginning at 200 or 250 d of age.

Pigs weaned from the sow at 10 days of age respond to dietary energy source of manufactured liquid diets and exogenous porcine somatotropin

Previous research indicates that the neonatal pig does not alter feed intake in response to changes in the energy density of manufactured liquid diets. Also, the limited response of IGF-I to exogenous porcine ST (pST) previously observed in young pigs may be influenced by the source of dietary energy. Our objectives were to 1) determine the effect of a high-fat (HF; 25% fat and 4,639 kcal/kg ME; DM basis) or low-fat (LF; 2% fat and 3,481 kcal/kg ME; DM basis) manufactured liquid diet on pig performance; and 2) determine whether the limited response to exogenous pST in young pigs depends on the source of dietary energy. Two replicates of 60 pigs (n = 120; barrows and gilts distributed evenly), with an initial BW of 4,207 +/- 51 g, were weaned from the sow at 10 d of age and used in a randomized complete block design. Pigs were assigned by BW to one of six pens. Diets were formulated to provide a constant lysine:ME ratio and were fed on a pen basis for a duration of 9 d. On d 5, barrows and gilts within a pen were assigned randomly to receive either 0 or 120 microg of pST.kg BW(-1).d(-1) for 4 d. Pigs gained 336 +/- 9 g/d, which resulted in an ending BW of 7,228 +/- 120 g, regardless of dietary treatment (P > 0.15). Pigs fed the LF diet consumed 17% more DM per pen daily than pigs fed the HF diet (2,777 +/- 67 vs. 2,376 +/- 67 g/d, P < 0.01), but calculated ME intake did not differ between dietary treatments (P > 0.20). The G:F was 24% greater in HF- than in LF-fed pigs (P < 0.01). Plasma urea N concentrations were higher in the HF-fed pigs (11.0 +/- 0.6 mg/dL) than in pigs fed the LF diet (6.2 +/- 0.6 mg/dL; P < 0.05). Treatment with pST increased circulating IGF-I (P < 0.01) and decreased PUN (P < 0.01) concentration 32 and 25%, respectively, regardless of dietary treatment (P > 0.30). Circulating leptin averaged 1.8 +/- 0.1 ng/mL and was not affected by dietary treatment (P > 0.35) or pST (P > 0.40). These results suggest that the ST/IGF axis is responsive in the young pig and the increase in circulating IGF-I and growth is independent of the source of dietary energy. Also, young pigs respond to a lower energy density liquid diet with increased feed intake, without altering growth performance, apparently utilizing a mechanism other than circulating leptin.

The effect of cyadox supplementation on metabolic hormones and epidermal growth factor in pigs

This study was conducted to evaluate the effect of cyadox on endocrine hormones and growth factor in pigs. Forty-eight crossbred pigs (35±7 days) were randomly allotted to one of four treatments, with six replicate pens per treatment and two pigs per pen. Pigs were offered one of four diets including a control diet or the control diet supplemented with cyadox at either 25, 50 or 100 mg/kg for 8 weeks. Growth performance data and serum were collected every 2 weeks. Serum epidermal growth factor (EGF), insulin, thyroid hormones (tri-iodothyronine (T3) and thyroxine (T4)), and cortisol concentrations were determined. Results indicated that average daily gain (ADG) and gain/food ratio increased linearly and quadratically with increasing cyadox levels. The treatment containing cyadox at 50 mg/kg improved ADG by proportionately 0·241 and food efficiency by 0·25 (P<0·05) during the entire experiment. In our study, EGF (during weeks 4 to 8), insulin (during weeks 4 to 6), thyroid hormones (in week 4) concentrations increased quadratrically (P<0·05) and the cortisol concentrations (in week 4) decreased linearly (P<0·01) with increasing supplementation of cyadox. Pigs given 50 mg/kg cyadox diet had greater (P<0·05) EGF concentrations than pigs on other diets throughout the experiment. An increase (proportionately 0·22) in serum insulin concentrations in cyadox group was also observed (P<0·05) in week 4. From week 2 to week 4, the T4concentrations of cyadox group increased by 50% (P<0·05). Moreover, feeding cyadox to pigs elevated their serum T3concentrations (P<0·05) in the 4th week and 8th week. The cortisol concentrations of cyadox group were decreased (P<0·05) in week 4. These results suggest that cyadox improve pig performance by altering concentrations of peripheral metabolic hormones and growth factor.

Impact of research with cattle, pigs, and sheep on nutritional concepts: body composition and growth

Studies with pigs, cattle, and sheep have provided a wealth of information regarding growth and body composition. Most of this information has been obtained using the standard methods for measuring the body composition of meat animals, which consist of dissection and chemical analysis. These methods have been used with meat animals to validate a variety of in vivo techniques that are used in both animal and human body composition studies. Research on the growth and body composition of meat animals has provided important concepts regarding the relation between growth and composition, including chemical maturity, the effects of severe undernutrition, partitioning of nutrients under various physiological conditions, the efficiency of nutrient utilization, and compensatory growth following a period of undernutrition. In addition, several genetic and physiological conditions affecting growth and body composition have been identified in meat animals that serve as important models for both animal and human growth.

Porcine somatotropin and cysteamine hydrochloride improve growth performance and reduce back fat in finisher gilts

Porcine somatotropin (pST) treatment of pigs consistently improves daily gain and feed conversion ratio but the daily injections involved can be problematic. The sulfhydryl compound cysteamine hydrochloride (CSH) increases somatotropin secretion in several species, possibly through inhibition of somatostatin secretion. Therefore, it is possible that dietary CSH supplementation may provide a dietary means of increasing pST secretion and improving growth performance in finisher pigs. Eighteen female crossbred (Large white × Landrace) gilts (59.2 kg) were allocated to one of three treatments with the respective factors being a control diet, dietary CSH (0.7 g/kg) and intramuscular pST (5 mg/day) for 5 weeks. After slaughter the whole half carcass was cut into primal cuts which were then dissected to a retail level into lean, fat, bone and rind. Over the first 2 weeks of the study daily gain was increased by both pST (+46%, P < 0.001) and CSH (+12%, P < 0.05) while feed conversion ratio was decreased by pST (–30%, P < 0.001) and CSH (–9.4%, P = 0.08) over this period. Over the entire 5 weeks there was a large and sustained increase in daily gain in pigs treated with pST (+38%, P < 0.001), while dietary CSH tended to cause a more modest increase in daily gain (+7.4%, P = 0.06). As a result, final liveweight (+10.6 and +2.0 kg, respectively) and carcass weight (+5.8 and +1.6 kg, respectively) were increased by pST and CSH. Back fat was decreased by both pST and CSH (–1.7 and 1.0 mm, respectively). Total dissectible tissue was increased by pST (+9.1%, P < 0.001) and CSH (+3.3%, P < 0.05). In pigs treated with pST, the increased tissue was primarily as lean (+11.1%, P < 0.008) and bone (+17.8%, P = 0.017), whereas an accumulation of non significant increases in lean, rind and bone was responsible for the increased dissectible tissue in the carcass of pigs supplemented with CSH. In conclusion, dietary CSH increased daily gain and carcass weight and decreased FCR and P2 backfat, with responses being most pronounced over the first 2 weeks of dietary supplementation and not as great as those caused by exogenous pST treatment.

Lysine requirement of finishing pigs administered porcine somatotropin by sustained-release implant1,2

To alleviate the need for daily injection of porcine somatotropin (pST), a sustained-release implant (pSTSR) was devised that continuously delivers a daily dose of 2 mg of pST for 42 d. Ninety-six white composite (Large White x Landrace) finishing barrows (83.6 +/- 1.2 kg BW) were assigned to receive zero or two pSTSR implants (4 mg pST/d) and to consume one of six diets differing in total Lys concentration (0.29, 0.52, 0.75, 0.98, 1.21, or 1.44%, as-fed basis). Diets were formulated to be isocaloric and based on the ideal protein concept. Pigs were housed individually, allowed ad libitum access to feed and water, and slaughtered at 112 kg of BW. The pSTSR affected neither ADG (P = 0.88) nor 10th rib LM area (LMA; P = 0.51), but it decreased (P < 0.01) ADFI, average backfat thickness, 10th rib fat depth, weights of leaf fat and ham fat, improved (P < 0.05) G:F, and increased (P < 0.01) weights of four trimmed lean cuts (T-cuts), and percentages of ham lean and bone. Increasing total Lys increased ADG (quadratic; P < 0.05) and ADFI (linear; P < 0.01). The G:F, plasma urea N concentrations (PUN), and T-cuts were affected by the interaction pSTSR x dietary Lys (P < 0.01). Without pSTSR, the G:F did not differ (P = 0.37) among pigs fed 0.52% and greater total Lys. With pSTSR, the G:F was less (P < 0.05) for pigs fed 0.52% than 0.98 and 1.44% total Lys. Increases in dietary total Lys resulted in increased PUN (P < 0.01), and incremental increases were less in pSTSR-implanted pigs. Maximal yield of T-cuts was at 0.98% dietary total Lys in nonimplanted pigs and 1.21% total Lys in pSTSR-implanted pigs. Estimates of total Lys requirements of pigs without and with pSTSR, respectively, were 0.52 and 0.86% for growth (ADG and G:F) and 0.73 and 0.88% for lean production (LMA and T-cuts). Equivalent apparent ileal digestible Lys requirements of pigs without and with pSTSR, respectively, were 0.44 and 0.68% for growth, and 0.62 and 0.75% for lean production. With ADFI of 3.5 kg daily, an intake of approximately 26.1 g of total daily Lys (0.75%) or 22.4 g of apparent ileal digestible Lys is needed to maximize lean production in finishing barrows receiving 4 mg pST/d via sustained-release implant.

Effects of dietary factors and other metabolic modifiers on quality and nutritional value of meat

A number of technologies that increase feed efficiency and lean tissue deposition while decreasing fat deposition have been developed in an effort to improve profitability of animal production. In general, the mode of action of these metabolic modifiers is to increase muscle deposition while often simultaneously reducing fat deposition. However, there have been some concerns that the focus on increasing production efficiency and lean meat yield has been to the detriment of meat quality. The aim of this review is to collate data on the effects of these metabolic modifiers on meat quality, and then discuss these overall effects. When data from the literature are collated and subject to meta-analyses it appears that conservative use of each of these technologies will result in a 5-10% (0.3-0.5kg) increase in shear force with a similar reduction in perception of tenderness. However, it should be borne in mind that the magnitude of these increases are similar to those observed with similar increases in carcass leanness obtained through other means (e.g. nutritional, genetic selection) and may be an inherent consequence of the production of leaner meat. To counter this, there are some other metabolic factors and dietary additives that offer some potential to improve meat quality (for example immuncastration) and it is possible that these can be used on their own or in conjunction with somatotropin, approved β-agonists, anabolic implants and CLA to maintain or improve meat quality.

Porcine somatotropin alters body composition and the distribution of fat and lean tissue in the finisher gilt

The present study was designed to determine whether porcine somatotropin (pST) reduces whole animal and belly fat using dual energy X-ray absorptiometry and manual dissection. The study utilised 24 Large White × Landrace gilts selected at 16 weeks of age with an approximate liveweight of 80 kg and housed in individual pens. Gilts were stratified on liveweight into 8 blocks and 1 pig from each block was assigned to either 0, 5 or 10 mg per day of pST. Pigs were fed ad libitum a wheat-based diet containing 200 g crude protein, 10.2 g available lysine and 14.6 MJ DE/kg, to ensure that responses to pST were expressed. Feed intake and liveweight were measured on a weekly basis. An Hologic QDR4500A dual energy X-ray absorptiometer was used to determine lean, fat and ash composition of pigs initially and again 4 weeks later at the end of the experiment. After slaughter, the composition of the whole half carcass as well as the shoulder, ham, belly and loin primal cuts was determined with dual energy X-ray absorptiometry and verified with manual dissection. Daily pST treatment decreased feed intake (3440, 2710 and 2537 g/day for 0, 5 or 10 mg pST per day, respectively; P<0.001) and decreased feed conversion ratio (2.95, 2.18 and 2.03 g/g; P<0.001) even though there was no significant effect on daily gain. Pigs treated with pST deposited more lean tissue (620, 839 and 873 g/day; P<0.05) and less fat (384, 218 and 176 g/day; P<0.001) than control animals, but there was no effect of pST on ash deposition. As a consequence, pigs treated with 5 and 10 mg pST/day contained 5 and 9 kg less dissectible fat than control gilts, respectively. A dose dependent decrease in belly, loin, ham and shoulder fat was also observed, although the decrease in belly fat was more pronounced than for the whole carcass and other primal cuts. Overall, pST treatment has the potential to decrease carcass and especially belly fat in pigs and increase consumer acceptance of pork in markets that place a premium on carcass fat and lean yield in the belly region. The results determined with dual energy X-ray absorptiometry were confirmed by manual dissection.

Technologies for the control of fat and lean deposition in livestock

When the ratio of lean to fat deposition is improved, so is feed conversion efficiency. Net benefits may include lower production costs, better product quality, less excretion of nitrogenous wastes into the environment, decreased grazing pressure on fragile landscapes, and reduced pressure on world feed supplies. However, finding a way to achieve these goals that is reliable, affordable, and acceptable to the majority of consumers has proved to be a major challenge. Since the European Union banned hormonal growth promoters (HGPs) 15 years ago, countries such as Australia and the United States have licensed new products for livestock production, including bovine growth hormone (GH), porcine and equine GH, and the beta-agonist ractopamine. There has also been considerable research into refining these products, as well as developing new technologies. Opportunities to improve beta-agonists include lessening their effects on meat toughness, reducing adverse effects on treated animals, and prolonging their duration of action. In the last regard, the combined use of a beta-agonist with GH, which upregulates beta-adrenoceptors, can produce an outstanding improvement in carcass composition and feed efficiency. Insulin-like growth factor-1 (IGF-1) mediates many of the actions of GH, but has proved to be of more use as a growth reporter/selection marker in pigs, than as a viable treatment. However, a niche for this product could exist in the manipulation of neonatal growth, causing a life-long change in lean:fat ratio. Another significant advance in endocrinology is the discovery of hormones secreted by muscle and fat cells, that regulate feed intake, energy metabolism, and body composition. Leptin, adiponectin and myostatin were discovered through the study of genetically obese, or double-muscled animals. Through genetic manipulation, there is potential to exploit these findings in a range of livestock species, although the production of transgenic animals is still hampered by the poor level of control over gene expression, and faces an uphill battle over consumer acceptance. There are several alternatives to HGPs and transgenics, that are more likely to gain world-wide acceptance. Genetic selection can be enhanced by using markers for polymorphic genes that control fat and lean, such as thyroglobulin, or the callipyge gene. Feed additives of natural origin, such as betaine, chromium and conjugated linoleic acid, can improve the fat:lean ratio under specific circumstances. Additionally, 'production vaccines' have been developed, which alter the neuro-endocrine system by causing an auto-immune response. Thus, antibodies have been used to neutralise growth-limiting factors, prolong the half-life of anabolic hormones, or activate hormone receptors directly. Unfortunately, none of these technologies is sufficiently well advanced yet to rival the use of exogenous HGPs in terms of efficacy and reliability. Therefore, further research is needed to find ways to control fat and lean deposition with due consideration of industry needs, animal welfare and consumer requirements.

Interrelationships between porcine somatotropin (pST), betaine, and energy level on body composition and tissue distribution of finisher boars

Fifty-six individually penned boars (initial weight 64 kg) were used to investigate the interactions between dietary betaine, dietary energy, and porcine somatotropin (pST) treatment. The study was a 2 × 2 × 2 factorial experiment with the respective factors being dietary betaine (0 or 1.5 g/kg) and energy level (80% or 100% ad libitum) and treatment with pST (0 or 5 mg/day). A Hologic QDR4500A Dual Energy X-ray Absorptiometer (DXA) was used to determine body composition of pigs at the beginning and end of the study at Day 35. After slaughter, the composition of the whole half-carcass as well as the shoulder, ham, belly, and loin primal cuts was determined with DXA and verified with manual dissection. The main effects of dietary betaine were most pronounced when dietary energy was restricted. Under these conditions, daily gain was increased by dietary betaine (1188 v. 1271 g/day, P = 0.049) and pST (1115 v. 1344 g/day, P < 0.001). When dietary energy was restricted, lean tissue deposition was increased by dietary betaine (830 v. 908 g/day, P = 0.032) and pST (764 v. 974 g/day, P < 0.001), and these effects were additive. As a result, the lean meat yield in the half-carcass was increased by both dietary betaine (23.9 v. 25.1 kg, P = 0.043) and pST (23.3 v. 25.7 kg, P < 0.001). Lean tissue responses in primal cuts were more variable but followed a similar pattern. There was little effect of either dietary betaine or pST on fat deposition. These data demonstrate that when energy intake is limiting the potential for growth (as is normally the case for the improved boar), then both dietary betaine and pST treatment, either alone or in combination, can increase lean tissue deposition without increasing fat deposition.

Exogenous porcine somatotropin administered to neonatal pigs at high doses can alter lifetime fat but not lean tissue deposition

The growth rate of the young pig is generally much less than its potential and may be constrained by endocrine status as well as nutrient intake. The aim of the present study was to determine whether porcine (p) somatotropin (ST) treatment of the sucking pig could alter subsequent body composition. Twelve mixed-parity cross-bred sows with an average litter size of ten piglets were used to nurse pigs for the present study. On day 1 of lactation, the median two male pigs (by weight) from each litter were randomly allocated to one of two doses of pST (0 or 1 mg/kg per d) until weaning on day 21. Pigs were weaned and offered feed ad libitum until slaughter at 134 d of age. Body composition was measured using dual-energy X-ray absorptiometry (DXA) at 21, 49, 77, 105 and 133 d of age. There was no significant difference in growth rates between day 1 and 21 of lactation in pigs injected with either saline (9 g/l NaCl/l) or pST (258 v. 246 g/d for control and pST-treated pigs respectively, P=0.61), and as a consequence there was no significant difference in liveweight at weaning (7.13 v. 6.84 kg, P=0.59). However, fat mass at weaning tended to be decreased (1.18 v. 0.96 kg, P=0.064), while the % fat in the body at weaning was significantly (16.7 v. 13.9 %, P=0.008) decreased by exogenous pST treatment. In the immediate post-weaning period there was a reduction in lean tissue deposition (347 v. 300 g/d, P=0.021) but no effect on fat deposition (35 v. 33 g/d, P=0.72). Over the entire weaning-to-slaughter period, pST treatment of neonatal pigs decreased the rate of fat deposition (130 v. 112 g/d, P=0.033), but had no effect on lean tissue deposition (550 v. 538 g/d, P=0.49). Therefore, treatment of nursing pigs with high doses of pST for a short period before weaning may provide a means of reducing the fat content of pork and pork products.

Body growth and substrate partitioning for fat and protein gain in weaned BALB/c mice treated with growth hormone

Previously we have found that recombinant human growth hormone (rhGH) (GH; 74 ng g body wt.(-1)) administration to weaned BALB/c male mice (fed 12% or 20% protein diet) induced a growth lag and subsequent repletion similar to the catch-up growth process. We studied the partitioning of feed and protein intakes between adipose and protein body stores through the linear relationships among them. The non-linear relationship of protein intake with body fat gain/protein gain (FG/PG) ratio was especially adequate in determining the partitioning of substrates. rhGH induced an increase in feed and protein intake utilization for body weight gain (50%) and fat gain (75-140%) over saline; macronutrient utilization was the greatest in rhGH-treated mice fed 20% protein. However, growth recovery of rhGH mice was anomalous and protein intake was derived primarily for fat gain. Mice fed 12% protein (treated and control) also derived protein intake in preference to fat stores. Treatment and diet had a cumulative effect with the result that rhGH-treated animals fed 12% protein showed the greatest FG/PG ratio (1.6), and therefore, the lowest efficiency to gain protein. Weaning is a critical stage in mice when treating with rhGH, as this could provoke a growth lag. The study showed that a high protein level is required to surpass the rhGH-induced lag, but it is not enough to obtain an enhanced protein deposition. Feeding a 12% protein diet was even worse as mice did not improve on the growth lag and substrates were directed mainly to body fat.

Instability studies of porcine somatotropin in aqueous solutions and the possible reagents for its stabilization

The instability of porcine somatotropin (pST) in various solutions and possible stabilization of the hormone by sugars and mild detergents were studied. Aggregation and decomposition of the hormone molecules in various pH solutions and under presence of sugar or detergent were monitored by gel permeation chromatography (GPC) or ultraviolet spectroscopy (UV). The pST is a very unstable hormone in an aqueous environment. It was found in this project that the peptide hormone underwent aggregation or decomposition quickly in acidic and alkaline solutions but slowly in neutral pH solutions. High losses of pST monomers were seen in concentrated solutions of the hormone. On the other hand, pST monomers were stabilized to a certain degree in glucose solutions and at a low concentration of urea. These results should facilitate the development of efficient controlled-release systems which are essential for commercializing porcine somatotropin.

Feed intake and protein skeletal muscle in growing mice treated with growth hormone: time course effects

The exogenous recombinant human growth hormone (rhGH) administration on gastrocnemius muscle growth performance and its contribution to body growth of male and female BALB/c mice fed a 12 % protein diet from 25 to 50 days of age, as well as the mechanism of utilization of feed intake to the lean muscle deposition were studied. Male and female weaning mice (21 days of age) were injected subcutaneously for 29 days with rhGH (74 ng x g(-1)) or saline vehicle (control). Feed intake and body weight (BW) were measured daily. At 25, 30, 35, 40, 45 and 50 days of age twenty mice were killed by cervical dislocation and the gastrocnemius muscle was isolated, weighed and the protein content was measured. The rhGH administration caused a biphasic response of BW and muscle growth as a consequence of age-specific feed intake changes. The initial feed intake fall induced the allometric proportion decreases in both muscle growth versus body growth and protein muscle versus muscle growth. That effect was due to ineffient utilization of energy and protein intake on protein muscle store. Later on, the self-controlled increase of feed intake leads to the recovery of muscle weight to control values, through nutrient partitioning toward non protein tissue showing a compensatory muscle growth. This suggests that a higher dietary protein level should be necessary for promoting the protein anabolic effect of GH during weaning.

Moderate doses of porcine somatotropin do not increase plasma insulin-like growth factor-I (IGF-I) or IGF binding protein-3

The growth rate of the young pig is generally much less than its potential and may be constrained by endocrine status as well as by nutrient intake. The aim of this study was to determine whether porcine somatotropin (pST) could increase growth in the nursing pig. Fourteen sows nursing litters of 6 (n = 7) or 12 (n = 7) piglets were utilized to establish a high and low plane of nutrition for sucking pigs. On Day 4 of lactation, the median two male pigs from each litter were randomly allocated to one of two doses of pST (0 or 60 micrograms/kg/d) until weaning on Day 31. Pigs were bled on Days 4, 13, 22, and 31 of lactation and the plasma was analyzed for insulin-like growth factor (IGF)-I, IGF-II, and IGF binding protein-3 (IGFBP-3). Pigs were weaned into conventional accommodation and further weighed on Days 63, 91, and 119. Pigs from litters of 6 grew more quickly and weighed 2.2 kg (P = 0.01) and 3.5 kg (P = 0.04) more than pigs from litters of 12 at 31 and 63 d of age, respectively. There was no effect of pST on preweaning growth of sucking pigs (261 vs. 258 g/d, P = 0.68), although growth rate increased in the final 3 d before weaning at 31 d (241 vs. 294 g/d, P = 0.01). IGFBP-3 was greater (1.09 vs. 0.78 micrograms/ml, P < 0.001), whereas IGF-I tended to be greater (206 vs. 176 ng/ml, P = 0.14), in pigs from the small litters. There was no effect of pST on plasma IGF-I (182 vs. 195 ng/ml, P = 0.454) or IGFBP-3 (0.93 vs. 0.94 microgram/ml, P = 0.85) concentrations. Plasma IGF-I and IGFBP-3 were highly correlated with the growth rate of nursing pigs (R = 0.638 and 0.756, respectively). There were no effects of pST (340 vs. 328 ng/ml, P = 0.48) or litter size (336 vs. 333 ng/ml, P = 0.88) on IGF-II. In conclusion, pST had no little or no effect on growth performance or plasma IGF-I, IGF-II, or IGFBP-3 in sucking pigs on either a high or low plane of nutrition.

Biology of somatotropin in growth and lactation of domestic animals

Impressive progress has been made during the past 15 years in our understanding of the biology of somatotropin (ST) in domestic animals. In part, this progress was sparked by advances in biotechnology that made feasible the production of large quantities of recombinant bovine ST (bST) and porcine ST (pST). The availability of recombinant bST and pST resulted in an exponential increase in investigations that explored their role in growth and lactation biology, as well as evaluated their potential for commercial use. Collectively, these studies established that administration of bST to lactating dairy cows increased milk yield, and treatment of growing pigs with pST markedly stimulated muscle growth and reduced fat deposition. In addition to these "efficacy" studies, a substantial number of investigations examined the mechanisms by which ST affects lactation and growth of domestic animals. This review summarizes the diverse physiological effects ST has on growth and lactation and discusses the underlying mechanisms that mediate these effects in domestic animals.

Nutrition, development and efficacy of growth modifiers in livestock species

Somatotropin (ST) and synthetic beta-adrenergic agonists (beta-AA) are growth-modifying agents that increase the rate and sometimes, the efficiency of protein deposition in lean tissues of livestock species. The ST-induced increase in muscle protein deposition is effected by a relatively modest increase in protein synthetic rate. This is possibly mediated by the endocrine influence of marked increases in circulating IGF (insulin-like growth factor)-I, and other ST-dependent components of the IGF system; mediation by locally expressed IGF-I may also occur. Increased muscle protein accretion in animals treated with beta-AA seems to be directly mediated by binding of the synthetic agonist to muscle beta-1 or beta-2 receptors, leading to increased muscle protein synthesis, possibly accompanied or followed by decreased protein degradation. This response is transient, due to down-regulation of beta-adrenergic receptors. Maximal responses of muscle protein accretion to both ST and beta-AA are attenuated by feeding inadequate levels of total protein or specific, limiting amino acids. For ST, but not beta-AA, this effect in growing pigs is partially offset by increased efficiency of utilization of absorbed amino acids for protein deposition, with predictable consequences for dietary protein and amino acid requirements. Both ST and beta-AA are less efficacious in promoting muscle protein deposition in very young animals. For ST, this is related to postnatal development of the somatotropic axis; a mechanistic explanation for the similar lack of effect of beta-AA is lacking. In both cases, this phenomenon must be considered against the very high inherent capacity and efficiency of lean tissue protein accretion in the neonate.

Somatotropin treatment reduces energy intake without altering protein intake in pigs selecting between high and low protein diets

The current experiment examined the effect of somatotropin (STH) on feed intake and diet selection in pigs selecting between high (24% CP) and low (12% CP) protein diets. Sixteen pigs (initial weight 69 +/- 2 kg) were individually penned and allowed to select between the diets for a 7-d pretreatment period and a 14-d treatment period during which time they received daily, subcutaneous injections of porcine somatotropin (0 or 4 mg/d). A 6-d withdrawal period followed. Feed intake was recorded daily. Over the 14-d treatment period, feed intake in pigs treated with STH was 21% less than that in the control group (2.49 vs. 3.17 kg/d, P < 0.01). The decrease in total intake was accounted for entirely by a decrease in the amount of the 12% CP diet selected (1.00 vs. 2.00 kg/d, P <0.01). STH-treated pigs altered their selection pattern such that energy intake was reduced, but total protein intake was unaffected. Control pigs selected a diet that was 15-16% crude protein throughout the study. STH-treated pigs selected a higher protein diet (18%, P < 0.02). During the withdrawal period, total feed intake began to normalize, such that by the third day of withdrawal, intake was not different than that in the control group. The recovery of total intake was accomplished by increased consumption of both diets rather than a specific normalization of low protein diet consumption. The results indicate that pigs treated with STH decrease feed intake, which is due to a decrease in the amount of 12% CP diet consumed. The change in dietary selection pattern is likely associated with a change in energy retention (carcass lipid + protein) associated with the STH-induced changes in composition of gain.